OneSkin key facts
as of Oct 2026- Provider of a topical skin supplement intended to target the root causes of skin aging.
- OneSkin is valued at approximately $165.0M as of Oct 2026, set at its later-stage round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $42.0M across 4 recorded rounds; the latest was Early Stage VC ($20.4M) in May 2025.
- Notable investors include SOSV, Metaplanet Holdings, IndieBio, Able Partners, Unilever Ventures — 13 tracked in total.
- OneSkin has filed 4 Form Ds with the SEC since 2017, most recently Jun 2025 ($20.4M sold to 1 investors).
- Status: Privately Held (backing).
Valued at $165.0M at its later-stage round, Jun 2025. Nothing has traded since.
- ·The complete investor list: 13 names
- ·Watch OneSkin: the Monday email on marks, rounds and moves
OneSkin funding rounds
4 roundsWho backs OneSkin
13+Membership and data by Private Market View
OneSkin valuation
OneSkin was valued at $165 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has OneSkin raised?
OneSkin has raised $42 million across 4 recorded rounds since 2017. The largest was a $7 million Series A in Oct 2024; the most recent was a $20.4 million early-stage round in May 2025.
OneSkin has filed 4 Form Ds with the SEC since 2017, most recently in Jun 2025 ($20.4 million sold to 1 investor).
OneSkin investors
13 investors are on record for OneSkin, including SOSV, Metaplanet Holdings, IndieBio and Able Partners. By type, the record holds 5 venture capital firms and 1 private equity firm. The early-stage round in May 2025 drew 1 investor.
Comparable companies
Comparable personal products names by valuation on PrivateMarketView: Evolved By Nature ($560 million), Because Market ($99 million) and Joylux ($28.7 million).
About OneSkin
Provider of a topical skin supplement intended to target the root causes of skin aging. The company offers vegan supplements, made with ingredients that are suitable for all skin types, help to reduce the skin's biological age by decreasing the accumulation of aged cells, improving cellular repair capacity, and strengthening the epidermal skin barrier, enabling customers to improve their skin and support proper cell function.
- Industry
- Personal Products
- Sector
- Consumer Products and Services (B2C)
- HQ
- San Francisco, CA, United States
- Founded
- 2016
- Employees
- 50
- Website
- oneskin.co/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.